A potential hazard: interchanging fentanyl and sufentanil
Ward, C.F.; Sanford, T.J.
Anesthesiology 64(3): 410-411
1986
ISSN/ISBN: 0003-3022 PMID: 2937354 Document Number: 279010
Document emailed within 1 workday
Related Documents
Freye, E.; Dehnen-Seipel, H.; Latasch, L.; Behler, M.; Wilder-Smith, O.H. 1999: Slow EEG-power spectra correlate with haemodynamic changes during laryngoscopy and intubation following induction with fentanyl or sufentanil Acta Anaesthesiologica Belgica 50(2): 71-76Ikeda, T.; Ikeda, K.; Isshiki, A.; Herregods, L.; Rolly, G.; Miyake, T. 1990: Comparison of sufentanil and fentanyl anesthesia for coronary artery bypass grafting--changes in stress hormones Masui. Japanese Journal of Anesthesiology 39(9): 1218-1222
Mathews, H.M.; Furness, G.; Carson, I.W.; Orr, I.A.; Lyons, S.M.; Clarke, R.S. 1988: Comparison of sufentanil-oxygen and fentanyl-oxygen anaesthesia for coronary artery bypass grafting British Journal of Anaesthesia 60(5): 530-535
Satterlee, G.B.; Skora, I.A. 1991: Criteria for use of fentanyl citrate, sufentanil citrate, and alfentanil hydrochloride Clinical Pharmacy 10(8): 635-637
Caruana, R.J. 1989: First-use reactions: a potential hazard for referral centers International Journal of Artificial Organs 12(11): 688-691
Singh, Y.; Singh, N.; Narasimhan, K.L.; Mitra, S.K. 1998: Saline enemas--a potential hazard in newborns Indian Pediatrics 35(8): 799-800
Burry, H.C. 1974: Penicillamine and wound healing--a potential hazard? Postgraduate Medical Journal 50(Suppl 2): 75-76
De Castro, J.; Van de Water, A.; Wouters, L.; Xhonneux, R.; Reneman, R.; Kay, B. 1979: Comparative study of cardiovascular, neurological and metabolic side effects of 8 narcotics in dogs. Pethidine, piritramide, morphine, phenoperidine, fentanyl, R 39 209, sufentanil, R 34 995. II. Comparative study on the epileptoid activity of the narcotics used in high and massive doses in curarised and mechanically ventilated dogs Acta Anaesthesiologica Belgica 30(1): 55-69
Gallelli, J.F. 1982: Evaluating the potential hazard of handling antineoplastic drugs American Journal of Hospital Pharmacy 39(11): 1877
Waffarn, F.; Hodgman, J.E. 1979: Mercury vapor contamination of infant incubators: a potential hazard Pediatrics 64(5): 640-642
Shaner, A.; Strasser, A.; Petrovic, L. 1970: Potential health hazard of metallic mercury in small plant New York State Journal of Medicine 70(8): 952-954
Kimmelman, B.B.; Hillman, E.E. 1983: Formaldehyde vapor in the dental environment: absence of potential hazard Asdc Journal of Dentistry for Children 50(1): 55-57
Kunachak, S.; Sobhon, P. 1998: The potential alveolar hazard of carbon dioxide laser-induced smoke Journal of the Medical Association of Thailand 81(4): 278-282
Tereshchenko, L.G. 1984: Potential hazard of the effect of halogen derivatives of inorganic mercury on the body Vrachebnoe Delo 6: 111-113
Foster, A.H.; Kolobow, T. 1987: A potential hazard of ventilation during early separation from total cardiopulmonary bypass Journal of Thoracic and Cardiovascular Surgery 93(1): 150-151
Hashem, N.; Shawki, R. 1976: Cultured peripheral lymphocytes: one biologic indicator of potential drug hazard African Journal of Medicine and Medical Sciences 5(2): 155-163
De Castro, J.; Van de Water, A.; Wouters, L.; Xhonneux, R.; Reneman, R.; Kay, B. 1979: Comparative study of cardiovascular, neurological and metabolic side effects of 8 narcotics in dogs. Pethidine, piritramide, morphine, phenoperidine, fentanyl, R 39 209, sufentanil, R 34 995. III. Comparative study of the acute metabolic toxicity of the narcotics used in high and massive doses in curarised and mechanically ventilated dogs Acta Anaesthesiologica Belgica 30(1): 71-90
Skomarokhin, A.F.; Kogan, F.M.; Katsnel'son, B.A.; Saitov, V.A. 1986: Current status of the problem of the potential health hazard of artificial mineral fiber dust Gigiena Truda i Professional'nye Zabolevaniya (2): 1-7
Talaeva, I.G.; Artemova, T.Z. 1988: Current methods of evaluating the degree of potential epidemiologic hazard of the drinking-water supply Gigiena i Sanitariia 1988(8): 8-11
Rodríguez-Vélez, R.án.; Ortiz-Rivera, O.J.; Bower, B.; Gorowski, K.; Windemuth, A.; Villagra, D.; Kocherla, M.; Seip, R.L.; D'Agostino, D.; Vergara, C.; Ruaño, G.; Duconge, J. 2010: Exposure to non-therapeutic INR in a high risk cardiovascular patient: potential hazard reduction with genotype-guided warfarin (Coumadin) dosing Puerto Rico Health Sciences Journal 29(4): 402-408